How Can Drugmakers Handle New Pricing Pressures?
at Investor's Business Daily - Thu Dec 11, 4:38PM CST
The subject of drug pricing keeps getting hotter, though for most people it's a mysterious process. On Nov. 25, pharmacy benefit manager Express Scripts (ESRX) said that to rein in costs it's upping the number of drugs excluded from its 2015...
ESRX: 82.88 (-1.10), GILD: 104.13 (-0.18), AMGN: 164.53 (-1.55)
Allscripts Deploys eAuth ePA Solution, Boosts EHR Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 1:30PM CST
Healthcare information technology solutions provider, Allscripts Healthcare Solutions, Inc. (MDRX), recently announced the distribution of a new electronic prior authorization (ePA) solution named Allscripts eAuth
ESRX: 82.88 (-1.10), QSII: 14.80 (-0.47), MDRX: 11.51 (-0.13), MRGE: 3.42 (-0.06)
3 High-Yield Dividend Stocks to Buy in December
Motley Fool Staff - Motley Fool - Wed Dec 10, 1:15PM CST
Not all high-yield dividend stocks are created equal, and while some make good investments, some should be avoided at all costs. For example, some are highly volatile, and others might not be able to sustain their high payouts. At the other end of...
PMT: 21.92 (-0.37), PM: 84.42 (-1.55), NLY: 11.41 (-0.11), ESRX: 82.88 (-1.10), MRK: 57.72 (-1.62), AZN: 71.80 (-1.80), AGNC: 22.24 (-0.24), MO: 49.65 (-0.56), GSK: 42.42 (-0.93)
Express Scripts Up 15.1% Since SmarTrend Uptrend Call (ESRX)
Comtex SmarTrend(R) - Wed Dec 10, 11:12AM CST
SmarTrend identified an Uptrend for Express Scripts (NASDAQ:ESRX) on October 28th, 2014 at $73.81. In approximately 1 month, Express Scripts has returned 15.05% as of today's recent price of $84.92.
ESRX: 82.88 (-1.10)
Express Scripts launches electronic prior authorization solution
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 8:35AM CST
ESRX: 82.88 (-1.10), MDRX: 11.51 (-0.13)
Allscripts and Express Scripts Collaborate to Deploy Allscripts eAuth Electronic Prior Authorization Solution
GlobeNewswire - Wed Dec 10, 7:05AM CST
Allscripts (Nasdaq:MDRX) and Express Scripts (Nasdaq:ESRX) have announced the deployment of Allscripts eAuth, a new electronic prior authorization (ePA) solution that transacts an electronic prior authorization for Express Scripts patients, replacing the costly, time-consuming, and labor-intensive process of manual prior authorization.
ESRX: 82.88 (-1.10), MDRX: 11.51 (-0.13)
Many Americans on Long-Term Painkillers Take Potentially Fatal Drug Combinations
PR Newswire - Tue Dec 09, 6:00AM CST
Nearly 60 percent of patients on opioid pain treatments for long-term conditions were prescribed potentially dangerous mixtures of medications during the same time period, according to a report released today by Express Scripts (NASDAQ: ESRX). Two-thirds of patients on these medication mixtures were prescribed the drugs by two or more physicians, and nearly 40 percent filled their prescriptions at more than one pharmacy.
ESRX: 82.88 (-1.10)
Health Care Services Equities Technical Commentary - Express Scripts Holding, DaVita HealthCare Partners, Omnicare, Laboratory Corp. of America, and Catamaran
PR Newswire - Mon Dec 08, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Company (NASDAQ:ESRX), DaVita HealthCare Partners Inc. (NYSE: DVA), Omnicare Inc. (NYSE: OCR), Laboratory Corporation of America Holdings (NYSE: LH), and Catamaran Corporation (NASDAQ: CTRX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, December 05, 2014, the NASDAQ Composite ended at 4,780.76, up 0.24%, the Dow Jones Industrial Average advanced 0.33%, to finish the day at 17,958.79, and the S&P 500 closed at 2,075.37, up 0.17%. During the session five out of ten sectors ended in positive. The S&P 500 Health Care Sector Index ended the day at 817.34, up 0.77%, with the index also advancing 5.43% in the last one month. Register for your complimentary reports on these five stocks at:
CTRX: 49.10 (-1.02), OCR: 70.59 (-0.45), ESRX: 82.88 (-1.10), DVA: 73.40 (-1.11), LH: 101.92 (-2.08)
12 Under-the-Radar Stock Picks From Buffett, Icahn, Soros and Fellow Billionaires
at The Street - Mon Dec 08, 7:21AM CST
This holiday season, some Wall Street billionaires have more to celebrate than others. But the most rewarding stocks under their trees this year may surprise you.
RAI: 64.27 (-1.12), VIPS: 19.70 (-0.49), ARII: 48.79 (-0.55), LO: 62.55 (-0.63), TAP: 72.37 (-2.42), ILMN: 184.30 (-2.53), GOOG: 518.66 (-9.68), BITA: 69.18 (-1.66), DSKY: 17.51 (+1.48), WWAV: 33.83 (-0.67), TTWO: 28.14 (+1.07), JNJ: 104.43 (-2.29), RYAAY: 68.30 (-0.35), ESRX: 82.88 (-1.10), DVA: 73.40 (-1.11), EGO: 6.41 (-0.22), MHK: 153.79 (-2.83), FNV: 49.11 (-1.43), GLD: 117.41 (-0.28), RGLD: 67.48 (-0.30), SNY: 45.16 (-1.05), GRPN: 7.22 (-0.04), AAPL: 109.73 (-1.89)
The Art Of Valuation Jujitsu (Part 5): Express Scripts
Patrick C. Gregory, CFA - Seeking Alpha - Sun Dec 07, 10:00AM CST
Originally published on November 16, 2014 >> Read Parts 1 , 2 , 3 As we saw in Part 4 of this series, there are four inputs to an absolute value model: cash flow from existing assets, the expected growth in those assets over...
ESRX: 82.88 (-1.10)
Follow Billionaire Investing Strategies with These Stocks and ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 9:00AM CST
If you want to invest like a billionaire, consider buying these stocks or ETFs.
IPO: 22.83 (-0.07), PBS: 24.94 (-0.18), ESRX: 82.88 (-1.10), MOAT: 30.88 (-0.51), EBAY: 55.77 (-1.01), IBLN: 25.38 (-0.21), IEP: 92.56 (-3.31), BRK.B: 146.46 (-3.67), MA: 84.13 (-3.56)
CVS' Healthy Dividend Is About To Go Higher!
Dividend Appreciator - at Seeking Alpha - Mon Dec 01, 12:27PM CST
ESRX: 82.88 (-1.10), CVS: 89.94 (-0.99), WAG: 74.50 (+1.49)
5 Stock-Moving Medtech Events This December
at Investor's Business Daily - Fri Nov 28, 1:18PM CST
December is usually a quiet month for medical tech news, but this year will bring a few potentially stock-moving events worth keeping an eye on. As you digest your Thanksgiving turkey, here are the top five in chronological order: By Dec. 5, biotech...
SNN: 32.48 (-0.41), ESRX: 82.88 (-1.10), GILD: 104.13 (-0.18), ACHN: 13.28 (-0.11), PFE: 30.95 (-0.70), MRK: 57.72 (-1.62), AZN: 71.80 (-1.80), INCY: 74.65 (-1.27), EW: 128.87 (-3.20), ABBV: 65.27 (-1.76), ENTA: 43.23 (-3.20), SYK: 92.00 (-1.41), NVS: 93.52 (-0.82)
After Yesterday's Rally of 1.02% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Nov 26, 3:55PM CST
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $81.35 to a high of $82.38. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $81.61 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 82.88 (-1.10)
Express Scripts Set to Possibly Pullback After Yesterday's Rally of 1.02%
Comtex SmarTrend(R) - Wed Nov 26, 3:55PM CST
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $81.35 to a high of $82.38. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $81.61 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 82.88 (-1.10)
Kinder Morgan Energy Partners, Prudential Financial Dominate Best Value Long-Term Bond Rankings
Donald van Deventer - at Seeking Alpha - Tue Nov 25, 11:06AM CST
KMI: 39.17 (-0.71), PRU: 86.66 (-3.13), UNH: 98.76 (-0.97), KMP: 102.03 (+1.98), COP: 62.45 (-1.16), CB: 101.84 (-1.46), AET: 87.30 (-0.82), ECA: 12.19 (-0.39), ESRX: 82.88 (-1.10), RDS.B: 63.77 (-1.77), RDS.A: 62.32 (-1.49), JPM: 60.04 (-1.10), WMB: 42.76 (-1.37), WPZ: 43.73 (-1.23)
Drug makers face pushback on pricey meds
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 7:18AM CST
ABT: 43.69 (-0.77), BIIB: 344.49 (+2.16), BIB: 128.83 (-3.16), PFE: 30.95 (-0.70), AMGN: 164.53 (-1.55), IBB: 306.10 (-3.95), LLY: 69.55 (-2.06), DRGS: 52.31 (-1.38), GSK: 42.42 (-0.93), BMY: 58.75 (-0.93), CELG: 114.49 (-2.25), JNJ: 104.43 (-2.29), ESRX: 82.88 (-1.10), BIS: 46.11 (+0.99), MRK: 57.72 (-1.62), AZN: 71.80 (-1.80), CVS: 89.94 (-0.99), ABBV: 65.27 (-1.76), SNY: 45.16 (-1.05), IRY: 47.43 (-0.71), IXJ: 101.03 (-1.47), NVS: 93.52 (-0.82)
Be Careful With Gilead - It May Be Time To Take Profits
Brendan O'Boyle - Seeking Alpha - Tue Nov 25, 6:10AM CST
Gilead Sciences (NASDAQ: GILD ) is a hugely successful pharmaceutical company headquartered in Foster City, CA. Recently the company has seen explosive growth due to the approval of Sovaldi, a miracle drug and effective cure for Hepatitis C. Gilead...
ESRX: 82.88 (-1.10), GILD: 104.13 (-0.18), PFE: 30.95 (-0.70), ABBV: 65.27 (-1.76), AAPL: 109.73 (-1.89)